Abstract
This study aims to describe the clinicopathological features and outcomes of patients who underwent orbital exenteration at a tertiary eye care center in south India. Retrospective chart reviews were performed on all patients undergoing orbital exenteration from January 1999 to December 2012. Parameters recorded include demographic data, clinical presentations, past medical or surgical interventions, exenteration notes, histopathological diagnosis, adjunctive treatment, follow-up examination findings, recurrences, complications, and their management. Orbital exenteration was performed on 119 orbits of 119 patients over a 14-year period. The mean age was 48.9 years (range 1–82 years). The indications were malignancies in 90.7 % (108/119), while 9.3 % (11/119) of cases were exenterated for non-malignant indications. Among the malignancies, the commonest tissue of origin was conjunctiva, noted in 45.4 % (49/108), followed by eyelids (25.9 %, 28/108), orbit (19.4 %, 21/108), and intraocular tissues (9.3 %, 10/108). The commonest malignancies noted in this series were an extensive ocular surface squamous neoplasia (OSSN) (44.4 %, 48/108) and sebaceous gland carcinoma of eyelids with an orbital involvement (18.5 %, 20/108). Extensive fungal granuloma (mucormycosis-4, aspergillosis-4) was the commonest (81.8 %, 9/11) indication among the non-malignant group. All complications were wound related, and none had a recurrence at a mean follow-up of 12.8 months. Extensive orbital involvement with OSSN and SGC were the commonest indications for exenteration. There is a need of creating awareness among general ophthalmologists in specific geographical regions regarding early diagnosis, standardized protocols of management, and appropriate referral.
Similar content being viewed by others
References
Bartisch G (1583) Ophthalmodoulcia. Dresden 3:208
Rahman I, Cook AE, Leatherbarrow B (2005) Orbital exenteration: a 13 year Manchester experience. Br J Ophthalmol 89:1335–1340
Shields JA, Shields CL, Demirci H, Honavar SG, Singh AD (2001) Experience with eyelid-sparing orbital exenteration. The 2000 Tullos O Coston Lecture. Ophthal Plast Reconstr Surg 17:355–361
Bartley GB, Garity JA, Waller RR, Henderson JW, Ilstrup DM (1989) Orbital exenteration at Mayo clinic 1967–1986. Ophthalmology 96:468–473
Pushker N, Kashyap S, Balasubramanya R et al (2004) Pattern of orbital exenteration in a tertiary eye care center in India. Clin Exp Ophthalmol 32:51–54
Mohr C, Esser J (1997) Orbital exenteration: surgical and reconstructive strategies. Graefes Arch Clin Exp Ophthalmol 235:288–295
Levin PS, Dutton JJ (1991) A 20 year series of orbital exenteration. Am J Ophthalmol 112:496–501
Rathbun JE, Beard C, Quickert MH (1971) Evaluation of 48 cases of orbital exenteration. Am J Ophthalmol 72:191–192
Naquin HA (1954) Exenteration of orbit. Arch Ophthalmol 51:850–851
Mouriaux F, Martinot V, Pellerin P, Patenotre P, Rouland JF, Constantinides G (1999) Survival after malignant tumors of the orbit and periorbita treated with exenteration. Acta Ophthalmol Scand 77:326–330
Soysal HG (2010) Orbital exenteration: a ten year experience of a general oncology hospital. Orbit 29:135–139
Nassab RS, Thomas SS, Murray D (2007) Orbital exenteration for advanced periorbital skin cancers: 20 years experience. J Plast Reconstr Aesthet Surg 60:1103–1109
Maheshwari R (2010) Review of orbital exenteration from an eye care center in western India. Orbit 29:35–38
Kaur A, Khattri M, Jaiswal V (2012) Pattern of orbital exenteration at a tertiary eye care center in North India. Nepal J Ophthalmol 4:64–67
Simons JN, Robinson DW, Masters FW (1996) Malignant tumors of the orbit and periorbital structures treated with exenteration. Plast Reconstr Surg 1996(37):100–104
Spaeth EB (1971) Information learned from 50 years of orbital exenteration. Trans Ophthalmol Soc UK 91:611–634
Kennedy RE (1979) Indications and surgical techniques for orbital exenteration. Ophthalmology 86:967–973
Putterman AM (1986) Orbital exenteration with spontaneous granulation. Arch Ophthalmol 104:139–140
Shields JA, Shields CL, Suvarnamani C, Tantisira M, Shah P (1991) Orbital exenteration with eyelid sparing: indications, techniques and results. Ophthal Surg 22:292–297
Wong JC, Thampy R, Cook A (2014) Life expectancy following orbital exenteration. Br J Ophthalmol (Epub)
Lee PS, Sedrak P, Guha-Thakurta N et al (2014) Imaging findings of recurrent tumors after orbital exenteration and free flap reconstruction. Ophthal Plast Reconstr Surg 30:315–321
Acknowledgments
The authors acknowledge the help of Ms. Sabera Banu in literature search and the provisions of it thereof.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no conflict of interest.
Ethical Statement
This study has been reviewed by the ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
Rights and permissions
About this article
Cite this article
Ali, M.J., Pujari, A., Dave, T.V. et al. Clinicopathological profile of orbital exenteration: 14 years of experience from a tertiary eye care center in South India. Int Ophthalmol 36, 253–258 (2016). https://doi.org/10.1007/s10792-015-0111-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-015-0111-5